Picture of Octave Specialty logo

OSG — Octave Specialty News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsAdventurousSmall CapValue Trap

Ambac Financial Group Inc expected to post breakeven results a share - Earnings Preview

* Ambac Financial Group Inc  AMBC.N   AMBC.K  is expected
to report results on February 26 for the period ending December
31 2024
    *  (Sales/Revenue Majority Basis is on Total revenues before
expenses and reorganization items)
    * ​LSEG's mean analyst estimate for Ambac Financial Group
Inc is
for breakeven results per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ambac
Financial
Group Inc is $17.00​, above​ its last closing price of $11.62.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  0.13        0.08       -0.46     Missed  -652
 Jun. 30 2024  0.17        0.15       0.18      Beat    20
 Mar. 31 2024  0.12        0.09       0.82      Beat    864.7​
 Dec. 31 2023  -0.03       -0.02      0.32      Beat    1,700
 ​​Sep.        -0.19       -0.18      2.00      Beat    1,181.
 30 2023                                                1
 Jun. 30 2023  -0.17       -0.16      0.07      Beat    143.8​
 Mar. 31 2023  -0.31       -0.31      -0.30     Beat    3.2
 Dec. 31 2022  0.81        0.88       4.18      Beat    376.8
 This summary was machine generated February 24 at 21:17 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Octave Specialty

See all news